Fred E. Cohen - Director at UroGen Pharma Ltd.

Issuer-level insider activity

Role
Director
Issuer symbol
URGN on Nasdaq
Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by Fred E. Cohen since 03 Jun 2025

Reported holdings for Fred E. Cohen in UroGen Pharma Ltd.

Form 4 holding Director

UroGen Pharma Ltd.

Security class
Stock Option (right ot buy)
Shares / value
10,000
Estimated value
Report date
06 Aug 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Fred E. Cohen in UroGen Pharma Ltd.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .